In the early 2000s, the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, found that extensive ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with huge upside potential.

A liquid supplement is going viral, with wellness influencers claiming it can do everything from clear up skin and curb ...

This abstract caught my attention; it is unusual in that it reports not a trial but a protocol of a trial of homeopathy. I think it deserves a short comment: Cancer-related fatigue (CRF) poses a ...

Europe’s economy is buckling under the pressure of climate regulation. Now the European Commission has signaled it may gradually revise its targets. The industrial math in Germany is unforgiving.

How the placebo effect works is astounding. To learn all about it, click through this gallery.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Neurocrine Biosciences' potential shines with robust assets, strong pipeline, and growth opportunities. Learn more about NBIX ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Compared with placebo, pramipexole added to antidepressants reduces symptoms significantly at 12 weeks in treatment-resistant depression, a trial finds.

Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...